nodes	percent_of_prediction	percent_of_DWPC	metapath
Meclofenamic acid—AKR1C3—Doxorubicin—ovarian cancer	0.504	1	CbGbCtD
Meclofenamic acid—PTGS2—ovarian follicle—ovarian cancer	0.0163	0.107	CbGeAlD
Meclofenamic acid—Niclosamide—STAT3—ovarian cancer	0.0104	0.614	CrCbGaD
Meclofenamic acid—PTGS1—oviduct—ovarian cancer	0.00751	0.0493	CbGeAlD
Meclofenamic acid—KCNQ2—gonad—ovarian cancer	0.00694	0.0456	CbGeAlD
Meclofenamic acid—AKR1C3—myometrium—ovarian cancer	0.00679	0.0446	CbGeAlD
Meclofenamic acid—KCNQ3—female reproductive system—ovarian cancer	0.00673	0.0442	CbGeAlD
Meclofenamic acid—AKR1C3—Vincristine—Vinorelbine—ovarian cancer	0.0065	0.554	CbGdCrCtD
Meclofenamic acid—KCNQ2—female reproductive system—ovarian cancer	0.0062	0.0407	CbGeAlD
Meclofenamic acid—KCNQ2—female gonad—ovarian cancer	0.00564	0.037	CbGeAlD
Meclofenamic acid—AKR1C3—uterine cervix—ovarian cancer	0.00529	0.0347	CbGeAlD
Meclofenamic acid—AKR1C3—Vinblastine—Vinorelbine—ovarian cancer	0.00523	0.446	CbGdCrCtD
Meclofenamic acid—AKR1C3—decidua—ovarian cancer	0.00504	0.0331	CbGeAlD
Meclofenamic acid—KCNQ2—testis—ovarian cancer	0.005	0.0328	CbGeAlD
Meclofenamic acid—AKR1C3—endometrium—ovarian cancer	0.00478	0.0314	CbGeAlD
Meclofenamic acid—Ileus paralytic—Paclitaxel—ovarian cancer	0.00467	0.0176	CcSEcCtD
Meclofenamic acid—Lupus erythematosus—Docetaxel—ovarian cancer	0.0046	0.0173	CcSEcCtD
Meclofenamic acid—ALOX5—decidua—ovarian cancer	0.00444	0.0292	CbGeAlD
Meclofenamic acid—AKR1C3—uterus—ovarian cancer	0.00441	0.0289	CbGeAlD
Meclofenamic acid—Leukopenia—Altretamine—ovarian cancer	0.00434	0.0164	CcSEcCtD
Meclofenamic acid—Anorexia—Altretamine—ovarian cancer	0.00377	0.0142	CcSEcCtD
Meclofenamic acid—AKR1C3—bone marrow—ovarian cancer	0.00374	0.0246	CbGeAlD
Meclofenamic acid—Systemic lupus erythematosus—Paclitaxel—ovarian cancer	0.00365	0.0137	CcSEcCtD
Meclofenamic acid—Ulcer—Melphalan—ovarian cancer	0.00363	0.0137	CcSEcCtD
Meclofenamic acid—AKR1C3—female gonad—ovarian cancer	0.0036	0.0237	CbGeAlD
Meclofenamic acid—AKR1C3—vagina—ovarian cancer	0.00358	0.0235	CbGeAlD
Meclofenamic acid—ALOX5—female reproductive system—ovarian cancer	0.00349	0.0229	CbGeAlD
Meclofenamic acid—SLCO1C1—testis—ovarian cancer	0.00348	0.0228	CbGeAlD
Meclofenamic acid—Decreased appetite—Altretamine—ovarian cancer	0.00344	0.013	CcSEcCtD
Meclofenamic acid—Fatigue—Altretamine—ovarian cancer	0.00341	0.0129	CcSEcCtD
Meclofenamic acid—Visual acuity reduced—Paclitaxel—ovarian cancer	0.0034	0.0128	CcSEcCtD
Meclofenamic acid—Acetylsalicylic acid—TP53—ovarian cancer	0.00339	0.201	CrCbGaD
Meclofenamic acid—Colitis—Topotecan—ovarian cancer	0.00337	0.0127	CcSEcCtD
Meclofenamic acid—ALOX5—bone marrow—ovarian cancer	0.0033	0.0216	CbGeAlD
Meclofenamic acid—AKR1C3—testis—ovarian cancer	0.0032	0.021	CbGeAlD
Meclofenamic acid—ALOX5—female gonad—ovarian cancer	0.00318	0.0209	CbGeAlD
Meclofenamic acid—Haemolytic anaemia—Chlorambucil—ovarian cancer	0.00317	0.0119	CcSEcCtD
Meclofenamic acid—Systemic lupus erythematosus—Docetaxel—ovarian cancer	0.00309	0.0117	CcSEcCtD
Meclofenamic acid—Asthenia—Altretamine—ovarian cancer	0.00284	0.0107	CcSEcCtD
Meclofenamic acid—ALOX5—testis—ovarian cancer	0.00282	0.0185	CbGeAlD
Meclofenamic acid—Haemolytic anaemia—Melphalan—ovarian cancer	0.00276	0.0104	CcSEcCtD
Meclofenamic acid—Erythema nodosum—Epirubicin—ovarian cancer	0.00267	0.0101	CcSEcCtD
Meclofenamic acid—SLCO1C1—lymph node—ovarian cancer	0.00252	0.0166	CbGeAlD
Meclofenamic acid—Vomiting—Altretamine—ovarian cancer	0.00252	0.00948	CcSEcCtD
Meclofenamic acid—Erythema nodosum—Doxorubicin—ovarian cancer	0.00247	0.00931	CcSEcCtD
Meclofenamic acid—Nausea—Altretamine—ovarian cancer	0.00235	0.00886	CcSEcCtD
Meclofenamic acid—AKR1C3—lymph node—ovarian cancer	0.00232	0.0152	CbGeAlD
Meclofenamic acid—Neutropenia—Chlorambucil—ovarian cancer	0.00231	0.00872	CcSEcCtD
Meclofenamic acid—PTGS2—myometrium—ovarian cancer	0.0023	0.0151	CbGeAlD
Meclofenamic acid—PTGS2—embryo—ovarian cancer	0.00221	0.0145	CbGeAlD
Meclofenamic acid—Stevens-Johnson syndrome—Chlorambucil—ovarian cancer	0.00219	0.00824	CcSEcCtD
Meclofenamic acid—Nocturia—Paclitaxel—ovarian cancer	0.00218	0.00821	CcSEcCtD
Meclofenamic acid—Stomatitis—Chlorambucil—ovarian cancer	0.00215	0.0081	CcSEcCtD
Meclofenamic acid—Blindness—Epirubicin—ovarian cancer	0.00209	0.00786	CcSEcCtD
Meclofenamic acid—Neutropenia—Topotecan—ovarian cancer	0.00206	0.00776	CcSEcCtD
Meclofenamic acid—ALOX5—lymph node—ovarian cancer	0.00204	0.0134	CbGeAlD
Meclofenamic acid—Neutropenia—Melphalan—ovarian cancer	0.00202	0.0076	CcSEcCtD
Meclofenamic acid—Colitis—Paclitaxel—ovarian cancer	0.00194	0.00731	CcSEcCtD
Meclofenamic acid—Blindness—Doxorubicin—ovarian cancer	0.00193	0.00727	CcSEcCtD
Meclofenamic acid—Stomatitis—Topotecan—ovarian cancer	0.00191	0.00721	CcSEcCtD
Meclofenamic acid—PTGS1—epithelium—ovarian cancer	0.00189	0.0124	CbGeAlD
Meclofenamic acid—Stomatitis—Melphalan—ovarian cancer	0.00187	0.00706	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Chlorambucil—ovarian cancer	0.00187	0.00706	CcSEcCtD
Meclofenamic acid—PTGS1—uterine cervix—ovarian cancer	0.00187	0.0123	CbGeAlD
Meclofenamic acid—PTGS2—epithelium—ovarian cancer	0.0018	0.0118	CbGeAlD
Meclofenamic acid—PTGS2—uterine cervix—ovarian cancer	0.00179	0.0117	CbGeAlD
Meclofenamic acid—Haemoglobin—Topotecan—ovarian cancer	0.00177	0.00668	CcSEcCtD
Meclofenamic acid—Haemorrhage—Topotecan—ovarian cancer	0.00176	0.00664	CcSEcCtD
Meclofenamic acid—Neutropenia—Vinorelbine—ovarian cancer	0.00176	0.00664	CcSEcCtD
Meclofenamic acid—Alopecia—Chlorambucil—ovarian cancer	0.00175	0.00659	CcSEcCtD
Meclofenamic acid—Haemoglobin—Melphalan—ovarian cancer	0.00174	0.00654	CcSEcCtD
Meclofenamic acid—Haemorrhage—Melphalan—ovarian cancer	0.00173	0.0065	CcSEcCtD
Meclofenamic acid—PTGS1—endometrium—ovarian cancer	0.00169	0.0111	CbGeAlD
Meclofenamic acid—Diclofenac—CXCL8—ovarian cancer	0.00167	0.0992	CrCbGaD
Meclofenamic acid—Colitis—Docetaxel—ovarian cancer	0.00164	0.00619	CcSEcCtD
Meclofenamic acid—Stomatitis—Vinorelbine—ovarian cancer	0.00164	0.00617	CcSEcCtD
Meclofenamic acid—PTGS2—endometrium—ovarian cancer	0.00162	0.0106	CbGeAlD
Meclofenamic acid—Agranulocytosis—Vinorelbine—ovarian cancer	0.00157	0.00591	CcSEcCtD
Meclofenamic acid—PTGS1—uterus—ovarian cancer	0.00156	0.0102	CbGeAlD
Meclofenamic acid—Alopecia—Topotecan—ovarian cancer	0.00156	0.00587	CcSEcCtD
Meclofenamic acid—Dermatitis exfoliative—Paclitaxel—ovarian cancer	0.00155	0.00586	CcSEcCtD
Meclofenamic acid—Leukopenia—Chlorambucil—ovarian cancer	0.00154	0.00581	CcSEcCtD
Meclofenamic acid—Alopecia—Melphalan—ovarian cancer	0.00153	0.00575	CcSEcCtD
Meclofenamic acid—PTGS2—uterus—ovarian cancer	0.00149	0.00978	CbGeAlD
Meclofenamic acid—Ill-defined disorder—Topotecan—ovarian cancer	0.00142	0.00537	CcSEcCtD
Meclofenamic acid—PTGS1—female reproductive system—ovarian cancer	0.0014	0.0092	CbGeAlD
Meclofenamic acid—Malaise—Topotecan—ovarian cancer	0.00138	0.00522	CcSEcCtD
Meclofenamic acid—Leukopenia—Topotecan—ovarian cancer	0.00137	0.00518	CcSEcCtD
Meclofenamic acid—Leukopenia—Melphalan—ovarian cancer	0.00135	0.00507	CcSEcCtD
Meclofenamic acid—Anorexia—Chlorambucil—ovarian cancer	0.00134	0.00505	CcSEcCtD
Meclofenamic acid—PTGS2—female reproductive system—ovarian cancer	0.00134	0.00879	CbGeAlD
Meclofenamic acid—Alopecia—Vinorelbine—ovarian cancer	0.00133	0.00502	CcSEcCtD
Meclofenamic acid—Jaundice cholestatic—Epirubicin—ovarian cancer	0.00131	0.00495	CcSEcCtD
Meclofenamic acid—Discomfort—Topotecan—ovarian cancer	0.00129	0.00486	CcSEcCtD
Meclofenamic acid—PTGS1—female gonad—ovarian cancer	0.00128	0.00837	CbGeAlD
Meclofenamic acid—PTGS1—vagina—ovarian cancer	0.00127	0.00832	CbGeAlD
Meclofenamic acid—PTGS2—bone marrow—ovarian cancer	0.00126	0.0083	CbGeAlD
Meclofenamic acid—Nocturia—Epirubicin—ovarian cancer	0.00125	0.00469	CcSEcCtD
Meclofenamic acid—Oedema—Melphalan—ovarian cancer	0.00123	0.00462	CcSEcCtD
Meclofenamic acid—Decreased appetite—Chlorambucil—ovarian cancer	0.00122	0.00461	CcSEcCtD
Meclofenamic acid—Ulcer—Epirubicin—ovarian cancer	0.00122	0.0046	CcSEcCtD
Meclofenamic acid—PTGS2—female gonad—ovarian cancer	0.00122	0.008	CbGeAlD
Meclofenamic acid—Ill-defined disorder—Vinorelbine—ovarian cancer	0.00122	0.00459	CcSEcCtD
Meclofenamic acid—Jaundice cholestatic—Doxorubicin—ovarian cancer	0.00122	0.00458	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00121	0.00458	CcSEcCtD
Meclofenamic acid—Fatigue—Chlorambucil—ovarian cancer	0.00121	0.00457	CcSEcCtD
Meclofenamic acid—PTGS2—vagina—ovarian cancer	0.00121	0.00795	CbGeAlD
Meclofenamic acid—Anorexia—Topotecan—ovarian cancer	0.00119	0.0045	CcSEcCtD
Meclofenamic acid—Neutropenia—Paclitaxel—ovarian cancer	0.00119	0.00447	CcSEcCtD
Meclofenamic acid—Malaise—Vinorelbine—ovarian cancer	0.00118	0.00446	CcSEcCtD
Meclofenamic acid—Leukopenia—Vinorelbine—ovarian cancer	0.00118	0.00443	CcSEcCtD
Meclofenamic acid—Anorexia—Melphalan—ovarian cancer	0.00117	0.00441	CcSEcCtD
Meclofenamic acid—Palpitations—Vinorelbine—ovarian cancer	0.00116	0.00437	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Chlorambucil—ovarian cancer	0.00116	0.00437	CcSEcCtD
Meclofenamic acid—Nocturia—Doxorubicin—ovarian cancer	0.00115	0.00434	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00115	0.00434	CcSEcCtD
Meclofenamic acid—PTGS1—testis—ovarian cancer	0.00113	0.00743	CbGeAlD
Meclofenamic acid—Ulcer—Doxorubicin—ovarian cancer	0.00113	0.00426	CcSEcCtD
Meclofenamic acid—Paraesthesia—Topotecan—ovarian cancer	0.00112	0.00424	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.00112	0.00422	CcSEcCtD
Meclofenamic acid—Urticaria—Chlorambucil—ovarian cancer	0.00112	0.00421	CcSEcCtD
Meclofenamic acid—Abdominal pain—Chlorambucil—ovarian cancer	0.00111	0.00419	CcSEcCtD
Meclofenamic acid—Renal failure—Paclitaxel—ovarian cancer	0.00111	0.00419	CcSEcCtD
Meclofenamic acid—Colitis—Epirubicin—ovarian cancer	0.00111	0.00418	CcSEcCtD
Meclofenamic acid—Discomfort—Vinorelbine—ovarian cancer	0.0011	0.00416	CcSEcCtD
Meclofenamic acid—Stomatitis—Paclitaxel—ovarian cancer	0.0011	0.00415	CcSEcCtD
Meclofenamic acid—Paraesthesia—Melphalan—ovarian cancer	0.0011	0.00415	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Paclitaxel—ovarian cancer	0.0011	0.00414	CcSEcCtD
Meclofenamic acid—Decreased appetite—Topotecan—ovarian cancer	0.00109	0.0041	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00108	0.00407	CcSEcCtD
Meclofenamic acid—Fatigue—Topotecan—ovarian cancer	0.00108	0.00407	CcSEcCtD
Meclofenamic acid—Constipation—Topotecan—ovarian cancer	0.00107	0.00404	CcSEcCtD
Meclofenamic acid—Decreased appetite—Melphalan—ovarian cancer	0.00107	0.00402	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00106	0.00399	CcSEcCtD
Meclofenamic acid—Fatigue—Melphalan—ovarian cancer	0.00106	0.00398	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Topotecan—ovarian cancer	0.00103	0.00389	CcSEcCtD
Meclofenamic acid—Colitis—Doxorubicin—ovarian cancer	0.00103	0.00387	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Topotecan—ovarian cancer	0.00102	0.00386	CcSEcCtD
Meclofenamic acid—Anorexia—Vinorelbine—ovarian cancer	0.00102	0.00385	CcSEcCtD
Meclofenamic acid—Haemoglobin—Paclitaxel—ovarian cancer	0.00102	0.00384	CcSEcCtD
Meclofenamic acid—Haemorrhage—Paclitaxel—ovarian cancer	0.00101	0.00382	CcSEcCtD
Meclofenamic acid—Asthenia—Chlorambucil—ovarian cancer	0.00101	0.0038	CcSEcCtD
Meclofenamic acid—Neutropenia—Docetaxel—ovarian cancer	0.001	0.00379	CcSEcCtD
Meclofenamic acid—Pruritus—Chlorambucil—ovarian cancer	0.000996	0.00375	CcSEcCtD
Meclofenamic acid—Urticaria—Topotecan—ovarian cancer	0.000995	0.00375	CcSEcCtD
Meclofenamic acid—Abdominal pain—Topotecan—ovarian cancer	0.00099	0.00373	CcSEcCtD
Meclofenamic acid—Urticaria—Melphalan—ovarian cancer	0.000974	0.00367	CcSEcCtD
Meclofenamic acid—Diarrhoea—Chlorambucil—ovarian cancer	0.000963	0.00363	CcSEcCtD
Meclofenamic acid—Paraesthesia—Vinorelbine—ovarian cancer	0.000962	0.00363	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Paclitaxel—ovarian cancer	0.000959	0.00361	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.00095	0.00358	CcSEcCtD
Meclofenamic acid—Tinnitus—Paclitaxel—ovarian cancer	0.000946	0.00356	CcSEcCtD
Meclofenamic acid—Renal failure—Docetaxel—ovarian cancer	0.000942	0.00355	CcSEcCtD
Meclofenamic acid—Stomatitis—Docetaxel—ovarian cancer	0.000934	0.00352	CcSEcCtD
Meclofenamic acid—Decreased appetite—Vinorelbine—ovarian cancer	0.000932	0.00351	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Docetaxel—ovarian cancer	0.000931	0.00351	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000925	0.00349	CcSEcCtD
Meclofenamic acid—Fatigue—Vinorelbine—ovarian cancer	0.000924	0.00348	CcSEcCtD
Meclofenamic acid—Constipation—Vinorelbine—ovarian cancer	0.000916	0.00345	CcSEcCtD
Meclofenamic acid—Asthenia—Topotecan—ovarian cancer	0.000899	0.00339	CcSEcCtD
Meclofenamic acid—Alopecia—Paclitaxel—ovarian cancer	0.000897	0.00338	CcSEcCtD
Meclofenamic acid—Vomiting—Chlorambucil—ovarian cancer	0.000895	0.00337	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Docetaxel—ovarian cancer	0.000894	0.00337	CcSEcCtD
Meclofenamic acid—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.000889	0.00335	CcSEcCtD
Meclofenamic acid—Pruritus—Topotecan—ovarian cancer	0.000886	0.00334	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Vinorelbine—ovarian cancer	0.000883	0.00333	CcSEcCtD
Meclofenamic acid—Asthenia—Melphalan—ovarian cancer	0.00088	0.00332	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000876	0.0033	CcSEcCtD
Meclofenamic acid—Pruritus—Melphalan—ovarian cancer	0.000868	0.00327	CcSEcCtD
Meclofenamic acid—Haemoglobin—Docetaxel—ovarian cancer	0.000864	0.00326	CcSEcCtD
Meclofenamic acid—Haemorrhage—Docetaxel—ovarian cancer	0.00086	0.00324	CcSEcCtD
Meclofenamic acid—Diarrhoea—Topotecan—ovarian cancer	0.000857	0.00323	CcSEcCtD
Meclofenamic acid—Urticaria—Vinorelbine—ovarian cancer	0.000851	0.00321	CcSEcCtD
Meclofenamic acid—Abdominal pain—Vinorelbine—ovarian cancer	0.000847	0.00319	CcSEcCtD
Meclofenamic acid—Diarrhoea—Melphalan—ovarian cancer	0.000839	0.00316	CcSEcCtD
Meclofenamic acid—Nausea—Chlorambucil—ovarian cancer	0.000836	0.00315	CcSEcCtD
Meclofenamic acid—Vision blurred—Paclitaxel—ovarian cancer	0.000832	0.00314	CcSEcCtD
Meclofenamic acid—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.000822	0.0031	CcSEcCtD
Meclofenamic acid—PTGS1—lymph node—ovarian cancer	0.00082	0.00538	CbGeAlD
Meclofenamic acid—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000819	0.00309	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Docetaxel—ovarian cancer	0.000813	0.00306	CcSEcCtD
Meclofenamic acid—Vomiting—Topotecan—ovarian cancer	0.000796	0.003	CcSEcCtD
Meclofenamic acid—Malaise—Paclitaxel—ovarian cancer	0.000796	0.003	CcSEcCtD
Meclofenamic acid—Leukopenia—Paclitaxel—ovarian cancer	0.000791	0.00298	CcSEcCtD
Meclofenamic acid—PTGS2—lymph node—ovarian cancer	0.000784	0.00514	CbGeAlD
Meclofenamic acid—Palpitations—Paclitaxel—ovarian cancer	0.00078	0.00294	CcSEcCtD
Meclofenamic acid—Vomiting—Melphalan—ovarian cancer	0.00078	0.00294	CcSEcCtD
Meclofenamic acid—Asthenia—Vinorelbine—ovarian cancer	0.000769	0.0029	CcSEcCtD
Meclofenamic acid—Alopecia—Docetaxel—ovarian cancer	0.00076	0.00286	CcSEcCtD
Meclofenamic acid—Pruritus—Vinorelbine—ovarian cancer	0.000758	0.00286	CcSEcCtD
Meclofenamic acid—Nausea—Topotecan—ovarian cancer	0.000744	0.0028	CcSEcCtD
Meclofenamic acid—Discomfort—Paclitaxel—ovarian cancer	0.000743	0.0028	CcSEcCtD
Meclofenamic acid—Diarrhoea—Vinorelbine—ovarian cancer	0.000733	0.00276	CcSEcCtD
Meclofenamic acid—Nausea—Melphalan—ovarian cancer	0.000729	0.00275	CcSEcCtD
Meclofenamic acid—Oedema—Paclitaxel—ovarian cancer	0.000721	0.00272	CcSEcCtD
Meclofenamic acid—Eosinophilia—Epirubicin—ovarian cancer	0.000717	0.0027	CcSEcCtD
Meclofenamic acid—Anorexia—Paclitaxel—ovarian cancer	0.000687	0.00259	CcSEcCtD
Meclofenamic acid—Vomiting—Vinorelbine—ovarian cancer	0.000681	0.00257	CcSEcCtD
Meclofenamic acid—Neutropenia—Epirubicin—ovarian cancer	0.000678	0.00255	CcSEcCtD
Meclofenamic acid—Leukopenia—Docetaxel—ovarian cancer	0.00067	0.00252	CcSEcCtD
Meclofenamic acid—Eosinophilia—Doxorubicin—ovarian cancer	0.000664	0.0025	CcSEcCtD
Meclofenamic acid—Palpitations—Docetaxel—ovarian cancer	0.000662	0.00249	CcSEcCtD
Meclofenamic acid—Insomnia—Paclitaxel—ovarian cancer	0.000652	0.00246	CcSEcCtD
Meclofenamic acid—Paraesthesia—Paclitaxel—ovarian cancer	0.000647	0.00244	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000641	0.00241	CcSEcCtD
Meclofenamic acid—Nausea—Vinorelbine—ovarian cancer	0.000637	0.0024	CcSEcCtD
Meclofenamic acid—Renal failure—Epirubicin—ovarian cancer	0.000635	0.00239	CcSEcCtD
Meclofenamic acid—Stomatitis—Epirubicin—ovarian cancer	0.00063	0.00237	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Epirubicin—ovarian cancer	0.000628	0.00237	CcSEcCtD
Meclofenamic acid—Neutropenia—Doxorubicin—ovarian cancer	0.000627	0.00236	CcSEcCtD
Meclofenamic acid—Decreased appetite—Paclitaxel—ovarian cancer	0.000627	0.00236	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000622	0.00234	CcSEcCtD
Meclofenamic acid—Fatigue—Paclitaxel—ovarian cancer	0.000621	0.00234	CcSEcCtD
Meclofenamic acid—Constipation—Paclitaxel—ovarian cancer	0.000616	0.00232	CcSEcCtD
Meclofenamic acid—Oedema—Docetaxel—ovarian cancer	0.000611	0.0023	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Epirubicin—ovarian cancer	0.000603	0.00227	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Paclitaxel—ovarian cancer	0.000594	0.00224	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000593	0.00223	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000589	0.00222	CcSEcCtD
Meclofenamic acid—Renal failure—Doxorubicin—ovarian cancer	0.000588	0.00221	CcSEcCtD
Meclofenamic acid—Haemoglobin—Epirubicin—ovarian cancer	0.000583	0.0022	CcSEcCtD
Meclofenamic acid—Stomatitis—Doxorubicin—ovarian cancer	0.000583	0.0022	CcSEcCtD
Meclofenamic acid—Anorexia—Docetaxel—ovarian cancer	0.000582	0.00219	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Doxorubicin—ovarian cancer	0.000581	0.00219	CcSEcCtD
Meclofenamic acid—Haemorrhage—Epirubicin—ovarian cancer	0.00058	0.00219	CcSEcCtD
Meclofenamic acid—Urticaria—Paclitaxel—ovarian cancer	0.000573	0.00216	CcSEcCtD
Meclofenamic acid—Abdominal pain—Paclitaxel—ovarian cancer	0.00057	0.00215	CcSEcCtD
Meclofenamic acid—Acetylsalicylic acid—ABCB1—ovarian cancer	0.000563	0.0334	CrCbGaD
Meclofenamic acid—Agranulocytosis—Doxorubicin—ovarian cancer	0.000558	0.0021	CcSEcCtD
Meclofenamic acid—Insomnia—Docetaxel—ovarian cancer	0.000553	0.00208	CcSEcCtD
Meclofenamic acid—Paraesthesia—Docetaxel—ovarian cancer	0.000549	0.00207	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Epirubicin—ovarian cancer	0.000548	0.00207	CcSEcCtD
Meclofenamic acid—Tinnitus—Epirubicin—ovarian cancer	0.000541	0.00204	CcSEcCtD
Meclofenamic acid—Haemoglobin—Doxorubicin—ovarian cancer	0.000539	0.00203	CcSEcCtD
Meclofenamic acid—Haemorrhage—Doxorubicin—ovarian cancer	0.000537	0.00202	CcSEcCtD
Meclofenamic acid—Decreased appetite—Docetaxel—ovarian cancer	0.000531	0.002	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000527	0.00199	CcSEcCtD
Meclofenamic acid—Fatigue—Docetaxel—ovarian cancer	0.000527	0.00198	CcSEcCtD
Meclofenamic acid—Constipation—Docetaxel—ovarian cancer	0.000522	0.00197	CcSEcCtD
Meclofenamic acid—Asthenia—Paclitaxel—ovarian cancer	0.000517	0.00195	CcSEcCtD
Meclofenamic acid—Alopecia—Epirubicin—ovarian cancer	0.000513	0.00193	CcSEcCtD
Meclofenamic acid—Pruritus—Paclitaxel—ovarian cancer	0.00051	0.00192	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Doxorubicin—ovarian cancer	0.000507	0.00191	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Docetaxel—ovarian cancer	0.000503	0.0019	CcSEcCtD
Meclofenamic acid—Tinnitus—Doxorubicin—ovarian cancer	0.0005	0.00189	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Docetaxel—ovarian cancer	0.0005	0.00188	CcSEcCtD
Meclofenamic acid—Diarrhoea—Paclitaxel—ovarian cancer	0.000493	0.00186	CcSEcCtD
Meclofenamic acid—Abdominal pain—Docetaxel—ovarian cancer	0.000483	0.00182	CcSEcCtD
Meclofenamic acid—Vision blurred—Epirubicin—ovarian cancer	0.000476	0.00179	CcSEcCtD
Meclofenamic acid—Alopecia—Doxorubicin—ovarian cancer	0.000474	0.00179	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Epirubicin—ovarian cancer	0.000468	0.00177	CcSEcCtD
Meclofenamic acid—Salicylic acid—ABCB1—ovarian cancer	0.000464	0.0275	CrCbGaD
Meclofenamic acid—Vomiting—Paclitaxel—ovarian cancer	0.000458	0.00173	CcSEcCtD
Meclofenamic acid—Malaise—Epirubicin—ovarian cancer	0.000455	0.00172	CcSEcCtD
Meclofenamic acid—Leukopenia—Epirubicin—ovarian cancer	0.000452	0.0017	CcSEcCtD
Meclofenamic acid—Palpitations—Epirubicin—ovarian cancer	0.000446	0.00168	CcSEcCtD
Meclofenamic acid—Vision blurred—Doxorubicin—ovarian cancer	0.00044	0.00166	CcSEcCtD
Meclofenamic acid—Asthenia—Docetaxel—ovarian cancer	0.000438	0.00165	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000433	0.00163	CcSEcCtD
Meclofenamic acid—Pruritus—Docetaxel—ovarian cancer	0.000432	0.00163	CcSEcCtD
Meclofenamic acid—Nausea—Paclitaxel—ovarian cancer	0.000428	0.00161	CcSEcCtD
Meclofenamic acid—Discomfort—Epirubicin—ovarian cancer	0.000425	0.0016	CcSEcCtD
Meclofenamic acid—Malaise—Doxorubicin—ovarian cancer	0.000421	0.00159	CcSEcCtD
Meclofenamic acid—Leukopenia—Doxorubicin—ovarian cancer	0.000418	0.00158	CcSEcCtD
Meclofenamic acid—Diarrhoea—Docetaxel—ovarian cancer	0.000418	0.00157	CcSEcCtD
Meclofenamic acid—Diclofenac—ABCB1—ovarian cancer	0.000415	0.0246	CrCbGaD
Meclofenamic acid—Palpitations—Doxorubicin—ovarian cancer	0.000413	0.00156	CcSEcCtD
Meclofenamic acid—Oedema—Epirubicin—ovarian cancer	0.000412	0.00155	CcSEcCtD
Meclofenamic acid—Discomfort—Doxorubicin—ovarian cancer	0.000393	0.00148	CcSEcCtD
Meclofenamic acid—Anorexia—Epirubicin—ovarian cancer	0.000393	0.00148	CcSEcCtD
Meclofenamic acid—Vomiting—Docetaxel—ovarian cancer	0.000388	0.00146	CcSEcCtD
Meclofenamic acid—Oedema—Doxorubicin—ovarian cancer	0.000381	0.00144	CcSEcCtD
Meclofenamic acid—Insomnia—Epirubicin—ovarian cancer	0.000373	0.0014	CcSEcCtD
Meclofenamic acid—Paraesthesia—Epirubicin—ovarian cancer	0.00037	0.00139	CcSEcCtD
Meclofenamic acid—Anorexia—Doxorubicin—ovarian cancer	0.000363	0.00137	CcSEcCtD
Meclofenamic acid—Nausea—Docetaxel—ovarian cancer	0.000363	0.00137	CcSEcCtD
Meclofenamic acid—Decreased appetite—Epirubicin—ovarian cancer	0.000358	0.00135	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000356	0.00134	CcSEcCtD
Meclofenamic acid—Fatigue—Epirubicin—ovarian cancer	0.000355	0.00134	CcSEcCtD
Meclofenamic acid—Constipation—Epirubicin—ovarian cancer	0.000352	0.00133	CcSEcCtD
Meclofenamic acid—Insomnia—Doxorubicin—ovarian cancer	0.000345	0.0013	CcSEcCtD
Meclofenamic acid—Paraesthesia—Doxorubicin—ovarian cancer	0.000342	0.00129	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Epirubicin—ovarian cancer	0.00034	0.00128	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000337	0.00127	CcSEcCtD
Meclofenamic acid—Decreased appetite—Doxorubicin—ovarian cancer	0.000331	0.00125	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000329	0.00124	CcSEcCtD
Meclofenamic acid—Fatigue—Doxorubicin—ovarian cancer	0.000329	0.00124	CcSEcCtD
Meclofenamic acid—Urticaria—Epirubicin—ovarian cancer	0.000327	0.00123	CcSEcCtD
Meclofenamic acid—Constipation—Doxorubicin—ovarian cancer	0.000326	0.00123	CcSEcCtD
Meclofenamic acid—Abdominal pain—Epirubicin—ovarian cancer	0.000326	0.00123	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Doxorubicin—ovarian cancer	0.000314	0.00118	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000312	0.00117	CcSEcCtD
Meclofenamic acid—Urticaria—Doxorubicin—ovarian cancer	0.000303	0.00114	CcSEcCtD
Meclofenamic acid—Abdominal pain—Doxorubicin—ovarian cancer	0.000301	0.00114	CcSEcCtD
Meclofenamic acid—Asthenia—Epirubicin—ovarian cancer	0.000296	0.00111	CcSEcCtD
Meclofenamic acid—Pruritus—Epirubicin—ovarian cancer	0.000292	0.0011	CcSEcCtD
Meclofenamic acid—Diarrhoea—Epirubicin—ovarian cancer	0.000282	0.00106	CcSEcCtD
Meclofenamic acid—Asthenia—Doxorubicin—ovarian cancer	0.000274	0.00103	CcSEcCtD
Meclofenamic acid—Pruritus—Doxorubicin—ovarian cancer	0.00027	0.00102	CcSEcCtD
Meclofenamic acid—Vomiting—Epirubicin—ovarian cancer	0.000262	0.000987	CcSEcCtD
Meclofenamic acid—Diarrhoea—Doxorubicin—ovarian cancer	0.000261	0.000983	CcSEcCtD
Meclofenamic acid—Nausea—Epirubicin—ovarian cancer	0.000245	0.000922	CcSEcCtD
Meclofenamic acid—Vomiting—Doxorubicin—ovarian cancer	0.000242	0.000913	CcSEcCtD
Meclofenamic acid—Nausea—Doxorubicin—ovarian cancer	0.000226	0.000853	CcSEcCtD
Meclofenamic acid—AKR1C3—Disease—FASN—ovarian cancer	7.81e-05	0.00157	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PARP1—ovarian cancer	7.78e-05	0.00156	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—HRAS—ovarian cancer	7.77e-05	0.00156	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—HRAS—ovarian cancer	7.77e-05	0.00156	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—VEGFA—ovarian cancer	7.67e-05	0.00154	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—VEGFA—ovarian cancer	7.67e-05	0.00154	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CHMP4C—ovarian cancer	7.66e-05	0.00154	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—STAT3—ovarian cancer	7.6e-05	0.00152	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—STAT3—ovarian cancer	7.6e-05	0.00152	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—HDAC6—ovarian cancer	7.58e-05	0.00152	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—NRAS—ovarian cancer	7.58e-05	0.00152	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—NRAS—ovarian cancer	7.58e-05	0.00152	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—NRAS—ovarian cancer	7.49e-05	0.0015	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—IL6—ovarian cancer	7.43e-05	0.00149	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—IL6—ovarian cancer	7.43e-05	0.00149	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—SLC2A1—ovarian cancer	7.42e-05	0.00149	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	7.39e-05	0.00148	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—NME2—ovarian cancer	7.34e-05	0.00147	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—MAPK3—ovarian cancer	7.26e-05	0.00145	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—MAPK3—ovarian cancer	7.26e-05	0.00145	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	7.13e-05	0.00143	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—CXCL8—ovarian cancer	7.11e-05	0.00143	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.01e-05	0.0014	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.98e-05	0.0014	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—MYC—ovarian cancer	6.97e-05	0.0014	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	6.95e-05	0.00139	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—CDKN1B—ovarian cancer	6.95e-05	0.00139	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—MAPK1—ovarian cancer	6.9e-05	0.00138	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—MAPK1—ovarian cancer	6.9e-05	0.00138	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—EGFR—ovarian cancer	6.9e-05	0.00138	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—EGFR—ovarian cancer	6.9e-05	0.00138	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—CASP3—ovarian cancer	6.81e-05	0.00136	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—IL2—ovarian cancer	6.8e-05	0.00136	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—YAP1—ovarian cancer	6.71e-05	0.00134	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—BCL9—ovarian cancer	6.64e-05	0.00133	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—CCND1—ovarian cancer	6.63e-05	0.00133	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—XIAP—ovarian cancer	6.57e-05	0.00132	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	6.57e-05	0.00132	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—FASN—ovarian cancer	6.57e-05	0.00132	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—FASN—ovarian cancer	6.54e-05	0.00131	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—KRAS—ovarian cancer	6.52e-05	0.00131	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—KRAS—ovarian cancer	6.52e-05	0.00131	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—SLC5A5—ovarian cancer	6.46e-05	0.00129	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—KRAS—ovarian cancer	6.44e-05	0.00129	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—SLC5A5—ovarian cancer	6.43e-05	0.00129	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—MMP9—ovarian cancer	6.43e-05	0.00129	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—SMARCA4—ovarian cancer	6.4e-05	0.00128	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	6.39e-05	0.00128	CbGpPWpGaD
Meclofenamic acid—PTGS1—Selenium Micronutrient Network—IL6—ovarian cancer	6.36e-05	0.00128	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PPP2R1A—ovarian cancer	6.31e-05	0.00126	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—EREG—ovarian cancer	6.25e-05	0.00125	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—SLC2A1—ovarian cancer	6.24e-05	0.00125	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	6.22e-05	0.00125	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—SLC2A1—ovarian cancer	6.21e-05	0.00125	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.11e-05	0.00122	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.08e-05	0.00122	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—CYP1B1—ovarian cancer	5.98e-05	0.0012	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—CYP1B1—ovarian cancer	5.96e-05	0.00119	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CYTB—ovarian cancer	5.96e-05	0.00119	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PGR—ovarian cancer	5.86e-05	0.00117	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	5.82e-05	0.00117	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—ABCB1—ovarian cancer	5.63e-05	0.00113	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—HRAS—ovarian cancer	5.54e-05	0.00111	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—HRAS—ovarian cancer	5.54e-05	0.00111	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—HRAS—ovarian cancer	5.48e-05	0.0011	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—MAPK3—ovarian cancer	5.46e-05	0.0011	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PARP1—ovarian cancer	5.45e-05	0.00109	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—MYC—ovarian cancer	5.31e-05	0.00107	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—IL6—ovarian cancer	5.31e-05	0.00106	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—IL6—ovarian cancer	5.31e-05	0.00106	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PPP2R1A—ovarian cancer	5.3e-05	0.00106	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PPP2R1A—ovarian cancer	5.28e-05	0.00106	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.28e-05	0.00106	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.26e-05	0.00105	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PPP1CC—ovarian cancer	5.21e-05	0.00104	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—BRIP1—ovarian cancer	5.21e-05	0.00104	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—MAPK1—ovarian cancer	5.2e-05	0.00104	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—EGFR—ovarian cancer	5.2e-05	0.00104	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	5.1e-05	0.00102	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	5.07e-05	0.00102	CbGpPWpGaD
Meclofenamic acid—PTGS2—Selenium Micronutrient Network—IL6—ovarian cancer	5.05e-05	0.00101	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—TERT—ovarian cancer	5.01e-05	0.001	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PPP1CC—ovarian cancer	4.94e-05	0.000989	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—ABCB1—ovarian cancer	4.92e-05	0.000987	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—ABCB1—ovarian cancer	4.91e-05	0.000983	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—AKT1—ovarian cancer	4.89e-05	0.000981	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—AKT1—ovarian cancer	4.89e-05	0.000981	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—TYMS—ovarian cancer	4.84e-05	0.000969	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—TYMS—ovarian cancer	4.82e-05	0.000966	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CYTB—ovarian cancer	4.73e-05	0.000948	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	4.72e-05	0.000947	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—CAV1—ovarian cancer	4.64e-05	0.000929	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	4.63e-05	0.000928	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	4.62e-05	0.000926	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	4.51e-05	0.000903	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	4.46e-05	0.000895	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PPP2R1A—ovarian cancer	4.42e-05	0.000885	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—IL6ST—ovarian cancer	4.39e-05	0.000881	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—TP53—ovarian cancer	4.36e-05	0.000875	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	4.35e-05	0.000872	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—APC—ovarian cancer	4.22e-05	0.000846	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PPP1CC—ovarian cancer	4.13e-05	0.000829	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—BRIP1—ovarian cancer	4.13e-05	0.000829	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—IL6—ovarian cancer	3.99e-05	0.000801	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	3.93e-05	0.000788	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—CAV1—ovarian cancer	3.9e-05	0.000781	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—CAV1—ovarian cancer	3.88e-05	0.000778	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.79e-05	0.000761	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—HDAC6—ovarian cancer	3.74e-05	0.00075	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.72e-05	0.000746	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	3.72e-05	0.000745	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PIK3CD—ovarian cancer	3.71e-05	0.000744	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.71e-05	0.000743	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	3.62e-05	0.000725	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PIK3CG—ovarian cancer	3.55e-05	0.000712	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	3.54e-05	0.000709	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	3.54e-05	0.000709	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PIK3CG—ovarian cancer	3.54e-05	0.000709	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TERT—ovarian cancer	3.51e-05	0.000703	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—YAP1—ovarian cancer	3.49e-05	0.0007	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.46e-05	0.000693	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	3.34e-05	0.00067	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—ERBB2—ovarian cancer	3.28e-05	0.000657	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CAV1—ovarian cancer	3.25e-05	0.000651	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—XIAP—ovarian cancer	3.24e-05	0.00065	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—MTOR—ovarian cancer	3.24e-05	0.000649	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PIK3CB—ovarian cancer	3.24e-05	0.000649	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SMARCA4—ovarian cancer	3.16e-05	0.000634	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—ESR1—ovarian cancer	3.13e-05	0.000627	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PIK3CD—ovarian cancer	3.12e-05	0.000625	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PIK3CD—ovarian cancer	3.11e-05	0.000623	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—EREG—ovarian cancer	3.08e-05	0.000618	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IL6ST—ovarian cancer	3.08e-05	0.000617	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	3.07e-05	0.000615	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.04e-05	0.000609	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—CDKN1B—ovarian cancer	3.04e-05	0.000609	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.01e-05	0.000604	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	2.97e-05	0.000595	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—APC—ovarian cancer	2.96e-05	0.000593	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PIK3CG—ovarian cancer	2.96e-05	0.000593	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—CTNNB1—ovarian cancer	2.87e-05	0.000575	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—FASN—ovarian cancer	2.85e-05	0.000571	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—SLC5A5—ovarian cancer	2.8e-05	0.000561	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PTEN—ovarian cancer	2.8e-05	0.00056	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—YAP1—ovarian cancer	2.77e-05	0.000556	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.74e-05	0.00055	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PIK3CB—ovarian cancer	2.72e-05	0.000545	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PIK3CB—ovarian cancer	2.71e-05	0.000543	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—SLC2A1—ovarian cancer	2.7e-05	0.000542	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—FASN—ovarian cancer	2.7e-05	0.000541	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PARP1—ovarian cancer	2.69e-05	0.000539	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.65e-05	0.000531	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PIK3CD—ovarian cancer	2.6e-05	0.000521	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CYP1B1—ovarian cancer	2.59e-05	0.00052	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SLC2A1—ovarian cancer	2.56e-05	0.000514	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	2.51e-05	0.000503	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—STAT3—ovarian cancer	2.5e-05	0.000501	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—NRAS—ovarian cancer	2.49e-05	0.0005	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.41e-05	0.000483	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—MAPK3—ovarian cancer	2.39e-05	0.000479	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PTEN—ovarian cancer	2.35e-05	0.000471	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PTEN—ovarian cancer	2.34e-05	0.000469	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—MYC—ovarian cancer	2.32e-05	0.000466	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PPP2R1A—ovarian cancer	2.3e-05	0.000461	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—ERBB2—ovarian cancer	2.3e-05	0.00046	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.29e-05	0.000459	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—MAPK1—ovarian cancer	2.27e-05	0.000456	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—EGFR—ovarian cancer	2.27e-05	0.000456	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PIK3CB—ovarian cancer	2.27e-05	0.000454	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MTOR—ovarian cancer	2.27e-05	0.000454	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—FASN—ovarian cancer	2.26e-05	0.000453	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—SLC5A5—ovarian cancer	2.22e-05	0.000446	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PPP2R1A—ovarian cancer	2.18e-05	0.000437	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CXCL8—ovarian cancer	2.18e-05	0.000436	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—SLC2A1—ovarian cancer	2.15e-05	0.00043	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—KRAS—ovarian cancer	2.15e-05	0.00043	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ABCB1—ovarian cancer	2.14e-05	0.000428	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CDKN1B—ovarian cancer	2.13e-05	0.000426	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.1e-05	0.000421	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—TYMS—ovarian cancer	2.1e-05	0.00042	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CASP3—ovarian cancer	2.08e-05	0.000418	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IL2—ovarian cancer	2.08e-05	0.000417	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CYP1B1—ovarian cancer	2.06e-05	0.000413	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CCND1—ovarian cancer	2.03e-05	0.000407	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CTNNB1—ovarian cancer	2.01e-05	0.000403	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PIK3CA—ovarian cancer	1.97e-05	0.000395	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MMP9—ovarian cancer	1.97e-05	0.000395	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PTEN—ovarian cancer	1.96e-05	0.000392	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PPP2R1A—ovarian cancer	1.83e-05	0.000366	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—HRAS—ovarian cancer	1.82e-05	0.000366	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.82e-05	0.000364	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—VEGFA—ovarian cancer	1.77e-05	0.000354	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—STAT3—ovarian cancer	1.75e-05	0.000351	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—NRAS—ovarian cancer	1.75e-05	0.00035	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—IL6—ovarian cancer	1.75e-05	0.00035	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TERT—ovarian cancer	1.73e-05	0.000347	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ABCB1—ovarian cancer	1.69e-05	0.00034	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CAV1—ovarian cancer	1.69e-05	0.000339	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MAPK3—ovarian cancer	1.67e-05	0.000335	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—TYMS—ovarian cancer	1.66e-05	0.000334	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PIK3CA—ovarian cancer	1.66e-05	0.000332	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PIK3CA—ovarian cancer	1.65e-05	0.000331	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MYC—ovarian cancer	1.63e-05	0.000326	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.61e-05	0.000324	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—AKT1—ovarian cancer	1.61e-05	0.000323	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CAV1—ovarian cancer	1.6e-05	0.000321	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MAPK1—ovarian cancer	1.59e-05	0.000319	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—EGFR—ovarian cancer	1.59e-05	0.000319	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PIK3CG—ovarian cancer	1.54e-05	0.000309	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—IL6ST—ovarian cancer	1.52e-05	0.000304	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—KRAS—ovarian cancer	1.5e-05	0.000301	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—APC—ovarian cancer	1.46e-05	0.000292	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PIK3CA—ovarian cancer	1.38e-05	0.000277	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—AKT1—ovarian cancer	1.35e-05	0.000272	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PIK3CD—ovarian cancer	1.35e-05	0.000271	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—AKT1—ovarian cancer	1.35e-05	0.00027	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CAV1—ovarian cancer	1.34e-05	0.000269	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TP53—ovarian cancer	1.34e-05	0.000268	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PIK3CD—ovarian cancer	1.28e-05	0.000257	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.28e-05	0.000257	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—HRAS—ovarian cancer	1.28e-05	0.000256	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IL6—ovarian cancer	1.22e-05	0.000245	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PIK3CG—ovarian cancer	1.22e-05	0.000245	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PIK3CB—ovarian cancer	1.18e-05	0.000236	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—ERBB2—ovarian cancer	1.13e-05	0.000227	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—AKT1—ovarian cancer	1.13e-05	0.000226	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PIK3CB—ovarian cancer	1.12e-05	0.000224	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MTOR—ovarian cancer	1.12e-05	0.000224	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PIK3CD—ovarian cancer	1.07e-05	0.000215	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CDKN1B—ovarian cancer	1.05e-05	0.00021	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PTEN—ovarian cancer	1.02e-05	0.000204	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CTNNB1—ovarian cancer	9.91e-06	0.000199	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PTEN—ovarian cancer	9.66e-06	0.000194	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PIK3CB—ovarian cancer	9.36e-06	0.000188	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—STAT3—ovarian cancer	8.64e-06	0.000173	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—NRAS—ovarian cancer	8.62e-06	0.000173	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MAPK3—ovarian cancer	8.25e-06	0.000165	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PTEN—ovarian cancer	8.09e-06	0.000162	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MYC—ovarian cancer	8.03e-06	0.000161	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MAPK1—ovarian cancer	7.85e-06	0.000157	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—EGFR—ovarian cancer	7.85e-06	0.000157	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—KRAS—ovarian cancer	7.42e-06	0.000149	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PIK3CA—ovarian cancer	7.19e-06	0.000144	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PIK3CA—ovarian cancer	6.81e-06	0.000137	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—HRAS—ovarian cancer	6.31e-06	0.000126	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—IL6—ovarian cancer	6.03e-06	0.000121	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—AKT1—ovarian cancer	5.87e-06	0.000118	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PIK3CA—ovarian cancer	5.71e-06	0.000114	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—AKT1—ovarian cancer	5.57e-06	0.000112	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—AKT1—ovarian cancer	4.66e-06	9.35e-05	CbGpPWpGaD
